Authors
Loading...
Integration of multi-omics data reveals immune microenvironment subtypes and drug response patterns in AML, indicating personalized treatment strategies.
Caroline Bret (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: